CURADERM BEC5 approved by health
authorities for the treatment of non melanoma skin cancers.
The superior qualities of CURADERM BEC5 over other
existing modalities for the treatment of skin cancers have
been documented in successfully treating Basal cell and
Squamous cell carcinomas as well Actinic Keratosis.
Curaderm BEC5 cream
contains the active ingredient BEC which is a constant mixture
of solasodine glycosides. BEC is extracted from the eggplant.
It works by binding, followed by interfering with the growth
of abnormal cells which are destroyed at all stages of their
lifecycles. Normal cells are not affected by Curaderm BEC5.
Curaderm BEC5 is a skin-use only (topical) medicine used to
treat: Non melanoma skin cancers in adults.
Curaderm BEC5 is a skin-use only (topical)
medicine to treat certain types of non-melanoma skin cancers.
The type of skin cancer needs to be diagnosed by your healthcare
provider.
